Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-14

Clinical Trial Update: Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating beta cell function and pharmacodynamics of HMS5552 in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMS5552

Snippet

Sponsor: Hua Medicine Limited | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED